Related Experiment Videos
Endocrine disorders with rheumatic manifestations
A C Schwarzer1, S J Preston, P M Brooks
1Royal North Shore Hospital, St. Leonards, Australia.
Current Opinion in Rheumatology
|December 1, 1989
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The management of rheumatoid arthritis.
The Australian journal of physiotherapy·2014
The clinical significance of indomethacin-probenecid interaction.
British journal of clinical pharmacology·2012
The effect of frusemide on indomethacin plasma levels.
British journal of clinical pharmacology·2012
Over the counter (OTC) oral remedies for arthritis and rheumatism: how effective are they?
Inflammopharmacology·2008
Costs and outcomes of total hip and knee joint replacement for rheumatoid arthritis.
Clinical rheumatology·2008
New approaches to the management of cutaneous lupus.
Current opinion in rheumatology·2026
"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".
Current opinion in rheumatology·2026
Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?
Current opinion in rheumatology·2026
Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.
Current opinion in rheumatology·2026
Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.
Current opinion in rheumatology·2026
Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.
Current opinion in rheumatology·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026